Previous 10 | Next 10 |
Amarin (NASDAQ: AMRN) stock climbed 58% last year, and that could be just the beginning. A new indication for its already-marketed drug could be a game changer for the company and its investors. The average analyst price target predicts an upside of 50% from its current price. That and...
Dr. Reddy's Laboratories Ltd (RDY) Q3 2020 Earnings Conference Call January 27, 2020, 08:00 ET Company Participants Amit Agarwal - IR Saumen Chakraborty - President &^CFO Erez Israeli - CEO Conference Call Participants Aditya Khemka - DSP Investment Managers Prakash A...
The following slide deck was published by Dr. Reddy's Laboratories Limited in conjunction with their 2020 Q3 earnings Read more ...
Dr. Reddy's (NYSE: RDY ): Q3 GAAP EPS of -$0.48. Revenue of $614M (+13.7% Y/Y) beats by $12.77M . Shares +4.8% in India Press Release More news on: Dr. Reddy's Laboratories Limited, Earnings news and commentary, Healthcare stocks news,
Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter ended December 31, 2019 under International Financial Reporting Standards (IFRS). * Excluding intangibles impairment of Rs. 1,320 Cr; Profit be...
Quick Take Aditx Therapeutics ( ADTX ) has filed to raise $10.5 million in an IPO of its common stock and warrants, according to an S-1 registration statement . The company is a pre-clinical developer of immune suppression drugs to assist in organ transplantation procedures. ADTX is sti...
The following slide deck was published by Dr. Reddy's Laboratories Limited in conjunction with this Read more ...
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the third quarter ended December 31, 2019 on Monday, January 27, 2020 after the Board Meeting. Summary of Events Earnings Call Following the release, the management of the Company w...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equ...
It's been tough-going for international investors. A stronger U.S. economy has led to more investment dollars flowing to U.S. equities than foreign companies, resulting in significant under-performance for foreign issues. For instance, the iShares MSCI EAFE ETF ( EFA ) has lagged the SPDR S&am...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...